-+ 0.00%
-+ 0.00%
-+ 0.00%

Saniona Grants AstronauTx Exclusive Development, Marketing Rights

MT Newswires·08/10/2026 03:37:43
Listen to the news
03:37 AM EDT, 08/10/2026 (MT Newswires) -- Saniona (SANION.ST) said Monday that biotechnology company AstronauTx exercised its option to acquire exclusive worldwide rights to research, develop and commercialize therapeutic candidates resulting from their 2023 partnership. In exchange for the rights, the Swedish biopharmaceutical company will receive $5 million in Series A shares of AstronauTx. Both parties signed the research collaboration and option agreement in 2023 to find new neurological treatments.